BSG and metastatic melanoma: Moreover, our study on a large series of primary and metastatic melanomas showed that CD147 overexpression was associated with reduced overall survival in patient with primary tumors, and was also correlated with metastasis and vertical invasion, demonstrating that CD147 is an important prognostic biomarker involved in melanoma’s aggressiveness [23].